Clinical Trial Combines New Symptom App with IBDoc

Read a recent article from University of Otago on the success of a new smartphone app, IBDSmart, in synergy with BÜHLMANN IBDoc calprotectin home test.

Highlight from this Article

“The study showed there was no difference in terms of quality of life for patients whether they used the apps or had face-to-face meetings,”  Associate Professor Schultz explains.”…not only do we have time to see urgent patients, but all the indirect costs for patients of attending appointments like having to travel, or take time off work, are also reduced.”

IBDoc and IBDSmart